Fufang Awei Suanna Asi Pilin Jiaonang (复方阿魏酸钠阿司匹林胶囊)复方阿魏酸钠阿司匹林胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 丽珠集团利民制药厂Chinese legal name: 丽珠集团利民制药厂
主要成分Active Ingredients
- 阿魏酸钠Awei Suanna
- 阿司匹林aspirin
- 桂利嗪Guili Qin
- 维生素BWeisheng Su
药物知识说明
阿魏酸钠是一种在国家药监局注册认定的药品。该药品含有桂利嗪、维生素b、阿司匹林-2dcb8c0d等成分。
该药品关联的活性成分包括：桂利嗪Guili Qin、维生素b、阿司匹林aspirin、阿魏酸钠Awei Suanna。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：丽珠集团利民制药厂Chinese legal name: 丽珠集团利民制药厂。
您可以探索含有相同成分的其他药品：桂利嗪-192927da成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 复方阿魏酸钠阿司匹林胶囊) is a medicine registered with the national drug regulatory authority. It contains aspirin and other recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 桂利嗪Guili Qin, 阿司匹林aspirin, 阿魏酸钠Awei Suanna.
Manufacturers recorded for this product: 丽珠集团利民制药厂Chinese legal name: 丽珠集团利民制药厂.
Explore other medicines containing the same ingredient: 桂利嗪 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 复方阿魏酸钠阿司匹林胶囊Recorded Chinese name: 复方阿魏酸钠阿司匹林胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 20粒20 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 丽珠集团利民制药厂Chinese legal name: 丽珠集团利民制药厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10900077
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10900077
Manufacturer
Chinese legal name: 丽珠集团利民制药厂 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10900077
生产企业
丽珠集团利民制药厂(国产)
适应症
适用于预防和治疗缺血性脑血管疾病，如短暂脑缺血性发作、脑缺血性中风、脑动脉硬化等。
用法用量
口服：常用量：一次1粒，一日3次，连续服用一个月为一个疗程，停药一周可继续服用下一个疗程，切勿随意增加剂量。
不良反应
未见明显的毒副反应。
禁忌
尚不明确。
注意事项
溃疡病及有出血倾向的患者慎用；高空作业者和驾驶员慎用。严格按说明书的剂量服用。
贮藏
遮光、密封、在干燥处保存。
规格
20粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.